OncoCyte Corporation (OCX)
3.19
0.41 (14.75%)
At close: Mar 04, 2025, 3:59 PM
3.10
-2.67%
After-hours: Mar 04, 2025, 07:06 PM EST
OncoCyte Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -27.78M | -72.9M | -64.1M | -29.93M | -22.43M | -15.75M | -19.38M | -11.17M | -8.73M | -4.99M | -3.5M |
| Depreciation & Amortization | 1.68M | 5.22M | 4.21M | 1.9M | 351K | 559K | 580K | 387K | 283K | 281K | 277K |
| Stock-Based Compensation | 6.57M | 10.04M | 6.84M | 5.07M | 3M | 1.48M | 1.63M | 922K | 1.81M | 318K | 326K |
| Other Working Capital | 677K | -1.66M | 373K | -273K | -2.3M | -9K | -638K | 2.11M | 1.28M | 2.93M | 2.13M |
| Other Non-Cash Items | 174K | 14.01M | 28.57M | -2.16M | 437K | 118K | 83K | 1.7M | 18K | 291K | 326K |
| Deferred Income Tax | n/a | n/a | -9.26M | -1.25M | 483K | 956K | 4.38M | n/a | 65K | n/a | -326K |
| Change in Working Capital | -3.97M | -1.94M | -2.2M | 399K | -1.55M | 993K | -686K | 2.34M | 2.33M | 3.22M | 2.18M |
| Operating Cash Flow | -23.32M | -45.57M | -35.94M | -25.98M | -19.71M | -11.65M | -13.38M | -7.52M | -4.23M | -1.16M | -710K |
| Capital Expenditures | -281K | -4.34M | -2.25M | -1.23M | -918K | -31K | -91K | -106K | -500K | -9K | -25K |
| Acquisitions | n/a | n/a | -11.71M | -10.51M | -11.24M | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | -4M | -11.24M | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 367K | n/a | n/a | 4M | 11.24M | n/a | 934K | n/a | 815K | 1.33M | n/a |
| Other Investing Acitivies | -1.02M | -4.34M | -13.35M | -7K | -252K | -240K | 934K | -75K | 815K | 1.33M | n/a |
| Investing Cash Flow | -932K | -4.34M | -13.96M | -11.75M | -12.41M | -31K | 843K | -181K | 315K | 1.32M | -25K |
| Debt Repayment | -117K | -1.43M | -1.53M | 695K | 1.36M | -1.18M | 1.58M | -114K | n/a | n/a | n/a |
| Common Stock Repurchased | -1.12M | n/a | -239K | -14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | -96K | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -1.54M | 4.39M | 2.15M | 1.31M | -2.35M | -201K | 8.38M | -555K | 4K | n/a | n/a |
| Financial Cash Flow | 12.19M | 35.81M | 78.36M | 22.8M | 47.87M | 12.11M | 9.97M | 9.88M | 11.65M | n/a | n/a |
| Net Cash Flow | -12.07M | -14.1M | 28.46M | -14.93M | 15.74M | 434K | -2.57M | 2.18M | 7.74M | 156K | -735K |
| Free Cash Flow | -23.61M | -49.91M | -38.19M | -27.21M | -20.63M | -11.68M | -13.48M | -7.63M | -4.73M | -1.17M | -735K |